Loading company…
Nintx develops therapies based on plant and microorganism interactions.
Nintx researches plant-based products intended to act on human biological targets and the microbiome. Its work focuses on therapies for multifactorial diseases. Founded in 2021, the company is based in Sao Paulo, Brazil. It raised series A funding led by Pitanga Invest in December 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in